$88.72
At close: Mar 21, 4:00 PM EDT
$88.72
0.000.00%
After Hours: Mar 21, 4:00 PM EDT
Comments
Loading...
Blueprint Medicines Earnings Estimates, EPS & Revenue | NASDAQ:BPMC | Benzinga
Blueprint Medicines reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
May 1
EPS Estimate
$-0.600
Quarterly Revenue Estimate
$155.96M
Annual Revenue
(as of Dec 31)
(as of Dec 31)
$508.82M
Analyze the earnings history of Blueprint Medicines using advanced sorting and filters.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| BPMC | Blueprint Medicines | -$1.32 | -$0.60 | — | — | $96.12M | $155.96M | — | — | 05/01/2025 | Get Alert |
| BPMC | Blueprint Medicines | -$1.82 | -$0.71 | -$0.79 | -11.27% | $71.96M | $145.18M | $146.37M | 0.82% | 02/13/2025 | Get Alert |
| BPMC | Blueprint Medicines | -$2.20 | -$0.96 | -$0.89 | 7.29% | $56.57M | $127.03M | $128.18M | 0.91% | 10/30/2024 | Get Alert |
| BPMC | Blueprint Medicines | -$2.19 | -$1.29 | -$0.80 | 37.98% | $57.57M | $103.00M | $138.16M | 34.13% | 08/01/2024 | Get Alert |
| BPMC | Blueprint Medicines | -$2.15 | -$1.66 | -$1.32 | 20.48% | $63.29M | $80.43M | $96.12M | 19.50% | 05/02/2024 | Get Alert |
| BPMC | Blueprint Medicines | -$2.65 | -$2.04 | -$1.82 | 10.78% | $38.78M | $66.64M | $71.96M | 7.98% | 02/15/2024 | Get Alert |
| BPMC | Blueprint Medicines | -$2.23 | -$2.37 | -$2.20 | 7.17% | $65.98M | $50.40M | $56.57M | 12.23% | 10/26/2023 | Get Alert |
| BPMC | Blueprint Medicines | -$2.68 | -$2.58 | -$2.19 | 15.12% | $36.55M | $45.00M | $57.57M | 27.93% | 08/02/2023 | Get Alert |
| BPMC | Blueprint Medicines | -$1.79 | -$2.67 | -$2.15 | 19.48% | $62.73M | $41.96M | $63.29M | 50.83% | 05/04/2023 | Get Alert |
| BPMC | Blueprint Medicines | -$0.99 | -$2.65 | -$2.65 | 0.00% | $107.02M | $34.43M | $38.78M | 12.64% | 02/16/2023 | Get Alert |
| BPMC | Blueprint Medicines | -$2.00 | -$2.49 | -$2.23 | 10.44% | $24.19M | $43.37M | $65.98M | 52.13% | 11/01/2022 | Get Alert |
| BPMC | Blueprint Medicines | -$1.86 | -$2.23 | -$2.68 | -20.18% | $27.30M | $37.24M | $36.55M | -1.86% | 08/02/2022 | Get Alert |
| BPMC | Blueprint Medicines | -$1.72 | -$1.94 | -$1.79 | 7.73% | $21.58M | $36.65M | $62.73M | 71.16% | 05/03/2022 | Get Alert |
| BPMC | Blueprint Medicines | -$1.53 | -$1.65 | -$0.99 | 40.00% | $34.11M | $102.69M | $107.02M | 4.22% | 02/16/2022 | Get Alert |
| BPMC | Blueprint Medicines | $11.16 | -$1.63 | -$2.00 | -22.70% | $745.12M | $42.47M | $24.19M | -43.05% | 10/28/2021 | Get Alert |
| BPMC | Blueprint Medicines | -$2.28 | -$1.86 | -$1.86 | 0.00% | $8.34M | $19.01M | $27.30M | 43.58% | 07/29/2021 | Get Alert |
| BPMC | Blueprint Medicines | -$2.11 | -$1.86 | -$1.72 | 7.53% | $6.17M | $17.25M | $21.58M | 25.08% | 04/29/2021 | Get Alert |
| BPMC | Blueprint Medicines | -$1.35 | -$1.62 | -$1.53 | 5.56% | $51.53M | $29.24M | $34.11M | 16.65% | 02/17/2021 | Get Alert |
| BPMC | Blueprint Medicines | -$1.93 | $7.72 | $11.16 | 44.56% | $9.14M | $631.57M | $745.12M | 17.98% | 10/29/2020 | Get Alert |
| BPMC | Blueprint Medicines | -$2.04 | -$2.14 | -$2.28 | -6.54% | $5.11M | $6.60M | $8.34M | 26.41% | 07/30/2020 | Get Alert |
| BPMC | Blueprint Medicines | -$1.98 | -$2.17 | -$2.11 | 2.76% | $730.00K | $5.44M | $6.17M | 13.36% | 05/06/2020 | Get Alert |
Blueprint Medicines (BPMC) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q4 | 2025-02-13 | $-0.79 | $-0.71 | -11.3 % |
| Q3 | 2024-10-30 | $-0.89 | $-0.96 | 7.29 % |
| Q2 | 2024-08-01 | $-0.80 | $-1.29 | 38.0 % |
| Q1 | 2024-05-02 | $-1.32 | $-1.66 | 20.5 % |
Blueprint Medicines (BPMC) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q4 | 2025-02-13 | $146.37M | $145.18M | 0.82 % |
| Q3 | 2024-10-30 | $128.18M | $127.03M | 0.91 % |
| Q2 | 2024-08-01 | $138.16M | $103.00M | 34.1 % |
| Q1 | 2024-05-02 | $96.12M | $80.43M | 19.5 % |
FAQ
When is Blueprint Medicines (NASDAQ:BPMC) reporting earnings?
Blueprint Medicines (BPMC) is scheduled to report earnings on May 1, 2025. The last reported earnings were for reported on February 13, 2025 for Q4.
What were the latest earnings per share (EPS) for Blueprint Medicines (NASDAQ:BPMC)?
The Actual EPS was $-0.79, which missed the estimate of $-0.71.
What were Blueprint Medicines’s (NASDAQ:BPMC) revenues?
The Actual Revenue was $146.4M, which beat the estimate of $145.2M.
Browse earnings estimates, EPS, and revenue on all stocks.